BeStock  
Markets › Compare › BVS vs CTKB

BVS vs CTKB

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
BVS · Bioventus$9.88 ▼ 0.70%
CTKB · Cytek Biosciences$6.12 ▼ 3.16%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

4990132173215Nov 24, '25May 26, '26Nov 20, '26
  • BVS +33.3%
  • CTKB +4.8%

Head to head

MetricBVSCTKB
Price$9.88$6.12
Change today▼ 0.70%▼ 3.16%
Market cap$676.53M$800.40M
Return, 3 months-29.5%+37.8%
Return, year to date+32.8%+21.2%
Return, 1 year+36.5%+4.1%
P/E (TTM)12.2–
P/B2.82.5
P/E percentile vs own 5y65th70th
Dividend yield––
Revenue growth (YoY, latest qtr)+2.7%+1.8%
Net profit growth (YoY)+71.2%-11.3%
Gross margin68.7%54.7%
Operating margin10.1%-21.1%
Net margin9.8%-39.1%
Return on equity28.2%-23.2%
Analyst target vs. price+68.7%+18.5%
Analyst buy share100%100%
RSI (14)2957
30-day volatility75.7%58.9%
Max drawdown, 1 year-35.3%-42.9%
Trend readStrong downtrendStrong uptrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • CTKB is the largest of the group by market value.
  • BVS has returned the most over the past year.
  • BVS is growing revenue fastest.
  • BVS keeps the most profit per dollar of sales.
  • CTKB has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top